Monday, April 5, 2010

Ranbaxy and Pfenex team up for biosimilars agreement

According to the Press Times of India, Ranbaxy Labs is teaming up with Pfenex to develop biosimilars. They are partnering in order to develop production strains and commercial making of biosimilars. A statement from Ranbaxy Labs claimed, "Under the terms of the agreement Pfenex is eligible to receive maintenance fees, milestone payments as well as royalty payments on any product sales derived from the agreement." Read the full article here.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment